Ion Gel ZCM-25® Clinical Phase 2 Human Dosing & Efficacy Study

February 15, 2021 | Public Relations

Ion Gel ZCM-25® Clinical Phase 2 Human Dosing & Efficacy Study with COFEPRIS Approval The Ion Gel ZCM-25® Clinical Phase […]

Ion Gel ZCM-25® Clinical Phase 1 Human Safety Study

October 5, 2020 | Public Relations

Bioemagno’s Clinical Pharmacology Unit recently completed a rigorous Phase 1 human safety study evaluating Ion Gel ZCM-25®, a Class II […]

June 15, 2014 | Public Relations

Verified Topical Skin Irritation Study Confirms ION-ZC1 Cream Is Safe for Human Use This topical skin irritation study evaluated the […]